May 24, 2022 / 06:45PM GMT
Kevin Caliendo - UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution
Good afternoon, everybody. Thank you for joining day 2 of the UBS Healthcare Conference. I'm Kevin Caliendo, healthcare supply chain managed care services analyst. With us today is the management team from Labcorp, and we have Adam Schechter, President and CEO; and Glenn Eisenberg, EVP and Chief Financial Officer. Gentlemen, thank you so much for coming to New York.
Adam H. Schechter - Laboratory Corporation of America Holdings - President, CEO & Chairman
Yes. Glad to be here. Thanks, Kevin, for having us. Good afternoon, everybody. And boy, it's great to be back in person. With laboratory business and everything we've done through COVID, we've been traveling, Glenn and I, throughout the pandemic, but we haven't gone to a lot of meetings where we have a lot of people in the room. So it's good to be here. It's good to see all of you.
It's certainly interesting times, interesting times for the world, interesting times for the U.S. and
Laboratory Corporation of America Holdings at UBS Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers